European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Improving monitoring and environmental risk assessment of pharmaceuticals, antimicrobial resistance and pathogens from terrestrial to aquatic environments

Descripción del proyecto

Proteger el planeta de la contaminación farmacéutica

La contaminación del suelo y los ecosistemas acuáticos por productos farmacéuticos, microorganismos resistentes a los antimicrobianos y agentes patógenos plantea una grave amenaza tanto para el medio ambiente como para el bienestar humano. El proyecto Pharm-ERA, que cuenta con el apoyo de las acciones Marie Skłodowska-Curie, reúne a investigadores, partes interesadas públicas y privadas y responsables políticos de la Unión Europea para abordar esta cuestión apremiante. A través de diez proyectos de doctorado que abarcan disciplinas científicas como la química ambiental, la ecotoxicología, la ecología microbiana, la biología molecular y la modelización, en Pharm-ERA se pretende desarrollar soluciones innovadoras y mejorar las técnicas de seguimiento y evaluación de riesgos ambientales. El objetivo último es proteger la diversidad y las funciones de la vida microbiana en los ecosistemas contaminados y, al mismo tiempo, garantizar la sostenibilidad del planeta y promover la salud humana y animal.

Objetivo

Global contamination of soil and aquatic ecosystems by pharmaceutical and microbiological pollutants (such as antimicrobial-resistant microorganisms and/or pathogens) raises severe concerns about impacts on ecosystem health and repercussions on humans and animals. Preserving ecosystems from adverse ecotoxicological effects of pharmaceuticals and their transformation products and limiting the environmental spread of antimicrobial resistance and pathogens is imperative to reach several UN Sustainable Development Goals as well as the European Green Deal, Water Framework Directive and Biodiversity Strategy for 2030. To meet these huge environmental and societal challenges, public and private stakeholders and EU policy makers require improved monitoring and Environmental Risk Assessment to protect microbial diversity and functions in contaminated ecosystems.
Pharm-ERA proposes a high-level interdisciplinary and intersectoral research and training network based on 10 doctoral projects covering scientific disciplines including environmental and analytical chemistry, microbial ecology, ecotoxicology, molecular biology (incl. multi-omics approaches) and chemical fate/effect modelling. Pharm-ERA involves 9 Beneficiaries (including 2 non-academics) and 6 Associated Partners (including 5 non-academics), committed to contribute to research, training, dissemination, communication and exploitation of results targeting end-users such as Environmental consultancies and agencies.
Pharm-ERA will provide EU with high-level scientific experts who will further shape and implement the next generation of environmental management strategies, EU guidelines and regulations to reduce the adverse environmental effects and risks of pharmaceuticals and the spread of antimicrobial resistance and pathogens in terrestrial and aquatic environments. This will ensure sustainability of our ecosystems, fostering positive impacts on human and animal health and well-being far beyond the Pharm-ERA project

Coordinador

INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Aportación neta de la UEn
€ 565 387,20
Dirección
147 RUE DE L'UNIVERSITE
75007 Paris
Francia

Ver en el mapa

Región
Ile-de-France Ile-de-France Paris
Tipo de actividad
Research Organisations
Enlaces
Coste total
Sin datos

Participantes (7)

Socios (12)